Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Europe dares to reopen as 200 millionth vaccine dose delivered

Mon, 10th May 2021 13:41

By Michael Gore and Estelle Shirbon

MADRID/LONDON, May 10 (Reuters) - As its vaccination drive
reaches a third of adults and COVID-19 infections ease, Europe
is starting to reopen cities and beaches, raising hopes that
this summer's holiday season can be saved before it is too late.

Exhilarated Spaniards chanting "freedom" danced in the
streets as a COVID-19 curfew ended in most of the country at the
weekend, while Greece reopened public beaches - with deckchairs
safely spaced.

With 200 million vaccine doses delivered, the European Union
is on track to achieve its goal of inoculating 70% of its adult
population by summer, Commission President Ursula von der Leyen
tweeted on Sunday.

And, in Germany, a first weekend of summer sun lifted
spirits after Health Minister Jens Spahn declared the third wave
of the pandemic finally broken.

Yet, Spahn warned: "The mood is better than the reality."

The national seven-day incidence of COVID-19 cases remains
high at 119 per 100,000 people, he said. "That makes it all the
more important to keep up the speed of the vaccination
campaign."

Across the EU, the seven-day incidence of COVID-19 is 185,
according to Our World in Data. That is far higher than in
countries such as Israel with 6, Britain (31), or the United
States (123), all of which made quicker early progress in their
vaccination drives.

HEAD START

In Britain, early orders and approval of vaccines and a
decision to give first doses to as many people as possible have
driven down infections and fatalities far more quickly.

Prime Minister Boris Johnson was expected to set out the
next phase of lockdown easing in England, giving the green light
to "cautious hugging" and allowing pubs to serve customers pints
inside after months of strict measures.

"The data reflects what we already knew - we are not going
to let this virus beat us," Johnson said ahead of an official
announcement later on Monday.

Vaccine deliveries were slower initially in the EU under its
centralised procurement strategy.

Now, with shots from BioNTech/Pfizer and Moderna relatively
plentiful, vaccinations as a share of the population in Europe
are growing while countries that made early advances see
slowdowns as they encounter hesitancy among the unvaccinated.

Some 31.6% of adults in 30 European countries have received
a first dose and 12% a full two-shot regime, the European Centre
for Disease Prevention and Control's COVID-19 Vaccine Tracker https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab
showed.

France expects to give 20 million first injections by
mid-May, and hit 30 million by mid-June.

With infection rates falling and occupancy in hospital
intensive care units declining, France plans to start relaxing
its curfew and allow cafes, bars and restaurants to offer
outdoor service from May 19.

PICKING AND CHOOSING

Improving supply has given countries greater freedom to
adapt their strategies following reports of very rare, but
sometimes fatal, blood clotting in people who received shots
from AstraZeneca and Johnson & Johnson.

Germany has decided to make the two vaccines available to
anyone who wants them, as long as they have been advised by a
doctor - an offer aimed at younger adults who would have to wait
their turn otherwise.

Norway's vaccine commission made a similar call on Monday,
saying the AstraZeneca and J&J shots should be made available to
volunteers. Some Italian regions are also offering both shots to
people under 60.

With some governments shortening the gaps between doses, and
plans for an EU digital "green pass" scheme in June for
travellers to provide proof of vaccination or immunity, people
cooped up for months are finally daring to make holiday plans.

"We're pinning our hopes on tourism," said Nikos Venieris,
who manages a beach in Alimos, an Athens suburb.

Tourism accounts for about a fifth of Greece's economy and
jobs, and the country can ill afford another lost summer. Greece
is lifting restrictions on vaccinated foreigners from May 15.

(Writing by Douglas Busvine
Additional reporting by Jordi Rubio, Terje Solsvik, Gwladys
Fouche, Matthias Blamont, Emilio Parodi, John Miller, Alan
Charlish and Phoebe Fronista
Editing by Giles Elgood)

More News
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more
9 Nov 2023 09:23

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.

Read more
9 Nov 2023 08:57

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.

Read more
9 Nov 2023 07:48

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.

Read more
9 Nov 2023 07:18

AstraZeneca hikes guidance after strong third quarter

(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.

Read more
3 Nov 2023 17:06

AstraZeneca plans next phase of trial on kidney drug combination data

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria.

Read more
3 Nov 2023 11:34

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy.

Read more
2 Nov 2023 15:57

UK earnings, trading statements calendar - next 7 days

Friday 3 November 
no events scheduled 
Monday 6 November 
Kingspan Group PLCTrading Statement
Kosmos Energy LtdQ3 Results
Ryanair Holdings PLCHalf Year Results
Tuesday 7 November 
Associated British Foods PLCFull Year Results
Beazley PLCQ3 Results
Direct Line Insurance Group PLCTrading Statement
dotdigital Group PLCFull Year Results
IWG PLCQ3 Results
Persimmon PLCTrading Statement
RS Group PLCHalf Year Results
Vaalco Energy IncQ3 Results
Watches of Switzerland Group PLCTrading Statement
Wednesday 8 November 
Conduit Holdings LtdQ3 Results
ITV PLCTrading Statement
JD Wetherspoon PLCQ1 Results
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Secure Trust Bank PLCTrading Statement
Smiths News PLCFull Year Results
Time Out Group PLCFull Year Results
Thursday 9 November 
3i Group PLCHalf Year Results
Apax Global Alpha LtdQ3 Results
AstraZeneca PLCQ3 Results
Auto Trader Group PLCHalf Year Results
B&M European Value Retail SAHalf Year Results
Domino's Pizza Group PLCTrading Statement
Endeavour Mining PLCQ3 Results
Flutter Entertainment PLCTrading Statement
IMI PLCTrading Statement
Indivior PLCQ3 Results
John Wood Group PLCTrading Statement
Lancashire Holdings LtdTrading Statement
National Grid PLCHalf Year Results
Regional REIT LtdTrading Statement
Renewi PLCHalf Year Results
S4 Capital PLCTrading Statement
Tate & Lyle PLCHalf Year Results
Taylor Wimpey PLCTrading Statement
TBC Bank Group PLCQ3 Results
TheWorks.co.uk PLCTrading Statement
Trakm8 Holdings PLCHalf Year Results
Urban Logistics REIT PLCHalf Year Results
Vistry Group PLCTrading Statement
WH Smith PLCFull Year Results
Wincanton PLCHalf Year Results
Wizz Air Holdings PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Nov 2023 08:59

AstraZeneca launches collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.

Read more
1 Nov 2023 07:33

AstraZeneca invests $220m in French gene-editing group Cellectis

(Sharecast News) - AstraZeneca is to invest in French biopharma group Cellectis to use its gene-editing technologies to develop next-gen therapeutics in areas like oncology, immunology and rare diseases.

Read more
30 Oct 2023 09:40

LONDON BROKER RATINGS: Jefferies cuts NatWest to underperform from buy

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
25 Oct 2023 11:04

PRESS: Soriot commits to five more years as AstraZeneca CEO - Times

(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday.

Read more
24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

Read more
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.